Dr.
Supported by an educational grant from Neurocrine Biosciences, Inc.
Hello dear colleagues, welcome to this podcast.
Welcome back dear colleagues to a discussion on the topic of the hidden toll of tardive dyskinesia: beyond movement symptoms.
Welcome dear colleagues and welcome to this conversation on mastering VMAT2 inhibitors, the goal being optimizing treatment s